Anchor Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.92M | Sell |
91,404
-751
| -0.8% | -$71.9K | 0.66% | 36 |
|
|
2025
Q4 | $8.85M | Sell |
92,155
-16,418
| -15% | -$1.59M | 0.72% | 27 |
|
|
2025
Q3 | $10.3M | Sell |
108,573
-902
| -0.8% | -$82.9K | 0.86% | 26 |
|
|
2025
Q2 | $9.54M | Buy |
109,475
+2,479
| +2% | +$210K | 0.84% | 27 |
|
|
2025
Q1 | $9.61M | Buy |
106,996
+112
| +0.1% | +$10K | 0.9% | 26 |
|
|
2024
Q4 | $8.54M | Sell |
106,884
-634
| -0.6% | -$54.9K | 0.8% | 29 |
|
|
2024
Q3 | $9.68M | Buy |
107,518
+1,271
| +1% | +$107K | 0.91% | 24 |
|
|
2024
Q2 | $8.36M | Buy |
106,247
+24,936
| +31% | +$2.04M | 0.86% | 28 |
|
|
2024
Q1 | $7.09M | Sell |
81,311
-1,378
| -2% | -$118K | 0.74% | 33 |
|
|
2023
Q4 | $6.81M | Buy |
82,689
+11,719
| +17% | +$893K | 0.78% | 32 |
|
|
2023
Q3 | $5.56M | Buy |
70,970
+10,109
| +17% | +$846K | 0.73% | 34 |
|
|
2023
Q2 | $5.36M | Buy |
60,861
+4,855
| +9% | +$418K | 0.68% | 37 |
|
|
2023
Q1 | $4.52M | Buy |
56,006
+5,558
| +11% | +$453K | 0.61% | 44 |
|
|
2022
Q4 | $3.92M | Buy |
50,448
+3,930
| +8% | +$319K | 0.56% | 49 |
|
|
2022
Q3 | $3.76M | Buy |
46,518
+1,296
| +3% | +$116K | 0.58% | 46 |
|
|
2022
Q2 | $4.06M | Buy |
45,222
+817
| +2% | +$82.8K | 0.59% | 47 |
|
|
2022
Q1 | $4.93M | Buy |
44,405
+2,977
| +7% | +$315K | 0.62% | 44 |
|
|
2021
Q4 | $4.29M | Buy |
41,428
+673
| +2% | +$77.9K | 0.53% | 52 |
|
|
2021
Q3 | $5.11M | Buy |
40,755
+402
| +1% | +$52K | 0.71% | 36 |
|
|
2021
Q2 | $5.01M | Buy |
40,353
+2,032
| +5% | +$255K | 0.69% | 35 |
|
|
2021
Q1 | $4.53M | Buy |
38,321
+2,022
| +6% | +$237K | 0.69% | 37 |
|
|
2020
Q4 | $4.25M | Buy |
36,299
+1,735
| +5% | +$191K | 0.76% | 34 |
|
|
2020
Q3 | $3.59M | Buy |
34,564
+1,145
| +3% | +$115K | 0.73% | 38 |
|
|
2020
Q2 | $3.06M | Buy |
33,419
+2,356
| +8% | +$226K | 0.69% | 40 |
|
|
2020
Q1 | $2.8M | Buy |
31,063
+560
| +2% | +$59.6K | 0.72% | 38 |
|
|
2019
Q4 | $3.46M | Buy |
30,503
+2,440
| +9% | +$268K | 0.74% | 34 |
|
|
2019
Q3 | $3.05M | Buy |
28,063
+388
| +1% | +$40.5K | 0.7% | 35 |
|
|
2019
Q2 | $2.7M | Buy |
27,675
+2,875
| +12% | +$262K | 0.64% | 41 |
|
|
2019
Q1 | $2.26M | Buy |
24,800
+273
| +1% | +$24.4K | 0.56% | 47 |
|
|
2018
Q4 | $2.23M | Buy |
24,527
+615
| +3% | +$57.5K | 0.64% | 44 |
|
|
2018
Q3 | $2.35M | Sell |
23,912
-1,115
| -4% | -$103K | 0.54% | 49 |
|
|
2018
Q2 | $2.14M | Sell |
25,027
-242
| -1% | -$20.2K | 0.53% | 50 |
|
|
2018
Q1 | $2.03M | Buy |
25,269
+111
| +0.4% | +$9.16K | 0.53% | 52 |
|
|
2017
Q4 | $2.03M | Buy |
25,158
+1,019
| +4% | +$81.6K | 0.54% | 54 |
|
|
2017
Q3 | $1.88M | Buy |
24,139
+1,643
| +7% | +$136K | 0.55% | 54 |
|
|
2017
Q2 | $2M | Buy |
22,496
+49
| +0.2% | +$4.13K | 0.66% | 48 |
|
|
2017
Q1 | $1.81M | Buy |
22,447
+1,795
| +9% | +$140K | 0.62% | 48 |
|
|
2016
Q4 | $1.47M | Hold |
20,652
| – | – | 0.55% | 54 |
|
|
2016
Q3 | $1.78M | Sell |
20,652
-440
| -2% | -$38.3K | 0.69% | 37 |
|
|
2016
Q2 | $1.83M | Sell |
21,092
-936
| -4% | -$75.7K | 0.72% | 35 |
|
|
2016
Q1 | $1.65M | Buy |
+22,028
| New | +$1.66M | 0.68% | 40 |
|
Other funds holding MDT
VCM
VPM
Anchor Investment Management's MDT Position: Q1 2026 in Review
Anchor Investment Management reduced its Medtronic (MDT) stake by 0.81% in Q1 2026, selling an estimated $71.9K and leaving 91,404 shares worth $7.92M. The position accounts for 0.66% of the portfolio, ranked #36.
Anchor Investment Management first reported a position in MDT in Q1 2016 and has held it in 41 quarters since. The position peaked at $10.3M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Anchor Investment Management held 91,404 shares of Medtronic worth $7.92M as of Q1 2026.
- Anchor Investment Management sold 751 Medtronic shares in Q1 2026, an estimated $71.9K.
- Medtronic made up 0.66% of Anchor Investment Management's portfolio in Q1 2026, its #36 holding.
- Anchor Investment Management first reported a position in Medtronic in Q1 2016 and has held it in 41 quarters since.
- Anchor Investment Management's Medtronic position peaked at $10.3M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.